Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Rheumatology

Assessing Your Fracture Risk: Beyond Bone Density

At a Glance

For people taking long-term steroids, fracture risk cannot be judged by bone density alone. A complete assessment combines DXA scores, a steroid-dose-adjusted FRAX calculation, and checks for silent spinal fractures, with TBS adding information about bone structure.

When you are taking steroids long-term, a standard bone density scan is only one piece of a much larger puzzle. Because Glucocorticoid-Induced Osteoporosis (GIOP) damages the microarchitecture (the internal honeycomb-like structure) of your bones faster than it reduces their density, your risk of a fracture is often much higher than a simple scan might suggest [1][2].

To accurately assess your risk, current guidelines from the American College of Rheumatology (ACR) recommend a comprehensive clinical fracture-risk assessment that combines a review of your medical history, bone density imaging, and an adjusted risk calculator [3].

1. The DXA Scan: Density vs. Quality

The Dual-Energy X-ray Absorptiometry (DXA) scan measures your Bone Mineral Density (BMD)—essentially how much “mineral” is packed into your bone [3]. The results are usually given as two different scores:

  • T-score: Used for postmenopausal women and men aged 50 years or older. This compares your bone density to that of a healthy young adult. A T-score of -2.5 or lower is the densitometric definition of osteoporosis [4].
  • Z-score: Used for premenopausal women and men younger than 50. This compares your density to people of your same age, sex, and ethnicity. A Z-score of -2.0 or lower means the bone density is “below the expected range for age” [4]. It is not an automatic diagnosis of urgent osteoporosis, but it requires careful clinical context to make treatment decisions.

The GIOP Gap: Steroids can make bone more “brittle” without immediately making it “thinner” on a DXA scan. You may have a “non-osteoporotic” T-score but still be at high risk for a fracture [5]. This is why relying on a DXA scan alone is often insufficient for patients on steroids [1].

2. FRAX: Calculating Your Probability

FRAX is a probability calculator that estimates your 10-year probability of suffering a major osteoporotic fracture or a hip fracture [6]. It is primarily validated for adults aged 40 to 90. It looks at your age, weight, prior fractures, parental hip fracture, rheumatoid arthritis, smoking, alcohol use, and steroid use [7].

Crucially, the standard FRAX tool only has a “yes/no” box for steroids, which assumes an average, medium-dose exposure. Because risk increases with the dose, your doctor must manually correct the FRAX result to account for your specific exposure [3][7]. If you are on a high dose, an unadjusted FRAX score will underestimate your true risk; if you are on a very low dose, it may overestimate it [8].

3. VFA and TBS: Looking Inside the Bone

Because spinal fractures in GIOP are often “silent” (occurring without pain), the 2022 ACR guidelines recommend Vertebral Fracture Assessment (VFA) or a spinal X-ray depending on your age, clinical risk, prior fracture, height loss, and symptoms [3].

  • VFA: This is a low-dose X-ray, often taken at the same time as your DXA, specifically designed to look for existing collapses in the vertebrae [9].
  • Trabecular Bone Score (TBS): This is an optional software adjunct that can be applied to your DXA images. It evaluates the texture and structure of the bone rather than just the density [10]. While not mandatory, a low TBS score indicates that the internal “honeycomb” structure of the bone is degraded, which is common in steroid users even when their BMD density appears normal [1][11].

Completeness Checklist

You can use this checklist to review your most recent bone health report. If any of these are missing, it is a good starting point for a conversation with your healthcare team.

  • [ ] Bone Mineral Density (BMD): Does the report include your T-scores (for adults over 50) or Z-scores (for younger adults)? [3]
  • [ ] Adjusted FRAX Score (if 40+): Was your FRAX score calculated, and did the doctor apply a correction for your specific steroid dose? [3][7]
  • [ ] Vertebral Imaging: Have you had a VFA or a lateral spinal X-ray to check for silent fractures based on your clinical risk? [3]
  • [ ] Risk Categorization: Based on these results, has your doctor clearly stated if you are in the “Low,” “Moderate,” “High,” or “Very High” risk category? [3]
  • [ ] Baseline Measurement: If you just started steroids, was this assessment done as soon as possible (generally within the first 6 months) to establish your baseline? [3]

Common questions in this guide

Can a normal DXA result still mean I have a high fracture risk from steroids?
Yes. Long-term glucocorticoids can damage the inner structure of bone faster than they lower bone density, so a DXA result outside the osteoporosis range does not rule out high fracture risk. Medical history, steroid exposure, and other tests are considered along with DXA.
Why does my FRAX score need to be adjusted for my steroid dose?
FRAX estimates your 10-year probability of a major osteoporotic fracture and a hip fracture. Its steroid question assumes average, medium-dose exposure, so a clinician should adjust the result for your actual dose; an unadjusted score may underestimate risk with high doses and overestimate it with very low doses.
What do the T-score and Z-score on a DXA report mean?
A T-score compares bone density with that of a healthy young adult and is generally used for postmenopausal women and men aged 50 or older. A Z-score compares density with people of the same age, sex, and ethnicity and is used for premenopausal women and men younger than 50. A Z-score of -2.0 or lower means the result is below the expected range for age and needs clinical context.
How can doctors find a silent spinal fracture?
A Vertebral Fracture Assessment, or VFA, is a low-dose X-ray often performed with a DXA scan to look for collapsed spinal bones. A lateral spinal X-ray may also be used, depending on your age, symptoms, height loss, prior fracture, and overall clinical risk.
What does a Trabecular Bone Score add to a bone density scan?
A Trabecular Bone Score, or TBS, is software applied to DXA images that assesses the texture of the bone’s internal structure rather than mineral density alone. A low TBS suggests degraded bone architecture, which can occur in people taking steroids even when their bone density appears normal.
What should be included in a complete steroid-related fracture-risk assessment?
The assessment should include bone mineral density with the appropriate T-score or Z-score, an FRAX calculation adjusted for the actual steroid dose when appropriate, and vertebral imaging when clinical risk indicates it. It should also identify whether fracture risk is low, moderate, high, or very high, with a baseline assessment generally obtained within the first six months after starting steroids.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Since steroids can weaken bone even if my DXA scan looks 'normal,' how does my FRAX score change when my specific steroid dose is factored in?
  2. 2.Based on the 2022 ACR guidelines, do I fall into the low, moderate, high, or very high fracture risk category?
  3. 3.Did my DXA scan include a Vertebral Fracture Assessment (VFA) to look for 'silent' fractures in my spine?
  4. 4.If a Trabecular Bone Score (TBS) is available, what does it tell us about the actual structure and quality of my bones?
  5. 5.How will my risk assessment change if my steroid dose is increased or tapered in the future?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    The impact of glucocorticoid therapy on trabecular bone score in older women.

    Paggiosi MA, Peel NF, Eastell R

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2015; (26(6)):1773-80 doi:10.1007/s00198-015-3078-1.

    PMID: 25743176
  2. 2

    Glucocorticoid-induced osteoporosis: 2019 concise clinical review.

    Adami G, Saag KG

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2019; (30(6)):1145-1156 doi:10.1007/s00198-019-04906-x.

    PMID: 30805679
  3. 3

    2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

    Humphrey MB, Russell L, Danila MI, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2023; (75(12)):2088-2102 doi:10.1002/art.42646.

    PMID: 37845798
  4. 4

    Prevention and treatment of glucocorticoid-induced osteoporosis in adults: recommendations from the European Calcified Tissue Society.

    Paccou J, Yavropoulou MP, Naciu AM, et al.

    European journal of endocrinology 2024; (191(6)):G1-G17 doi:10.1093/ejendo/lvae146.

    PMID: 39556468
  5. 5

    Bone Mass, Microstructure, and Strength Can Discriminate Vertebral Fracture in Patients on Long-Term Steroid Treatment.

    Shen J, Griffith JF, Zhu TY, et al.

    The Journal of clinical endocrinology and metabolism 2018; (103(9)):3340-3349 doi:10.1210/jc.2018-00490.

    PMID: 29982545
  6. 6

    Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis.

    Park SY, Gong HS, Kim KM, et al.

    Journal of bone metabolism 2018; (25(4)):195-211 doi:10.11005/jbm.2018.25.4.195.

    PMID: 30574464
  7. 7

    Use of Fracture Risk Assessment Tool in clinical practice and Fracture Risk Assessment Tool future directions.

    Zerikly R, Demetriou EW

    Women's health (London, England) 2024; (20()):17455057241231387 doi:10.1177/17455057241231387.

    PMID: 38529935
  8. 8

    Management of glucocorticoid-induced osteoporosis.

    Messina OD, Vidal LF, Wilman MV, et al.

    Aging clinical and experimental research 2021; (33(4)):793-804 doi:10.1007/s40520-021-01823-0.

    PMID: 33751462
  9. 9

    Updates on the Role of DXA in the Evaluation and Monitoring of Osteoporosis.

    Anupama S, Lim SY, Bolster MB

    Current rheumatology reports 2025; (27(1)):38 doi:10.1007/s11926-025-01205-9.

    PMID: 41174328
  10. 10

    Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice.

    Harvey NC, Glüer CC, Binkley N, et al.

    Bone 2015; (78()):216-24.

    PMID: 25988660
  11. 11

    Clinical Utility of Trabecular Bone Score (TBS) in Fracture Risk Assessment of Patients with Rheumatic Diseases Treated with Glucocorticoids.

    Nowakowska-Płaza A, Wroński J, Sudoł-Szopińska I, Głuszko P

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2021; (53(8)):499-503 doi:10.1055/a-1528-7261.

    PMID: 34384106

This page is for informational purposes only and does not constitute medical advice. Your healthcare professional should interpret your DXA, FRAX, vertebral imaging, TBS, and steroid exposure in the context of your individual care.

Get notified when new evidence is published on glucocorticoid-induced osteoporosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.